-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AvdVmzwzCAF23mOpzhrDAolcXVGK5jGjlVrJugq4Zsno13qATM3vGylEU/W/2OGV tTcAvQyOvDmOt2OMiBRdPQ== 0000897101-05-002600.txt : 20051209 0000897101-05-002600.hdr.sgml : 20051209 20051209102332 ACCESSION NUMBER: 0000897101-05-002600 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051209 DATE AS OF CHANGE: 20051209 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MINDICH BRUCE P CENTRAL INDEX KEY: 0001198674 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: HEARTS PLUS MANAGEMENT CORP STREET 2: 200 ROUTE 17 NORTH CITY: PARAMUS STATE: NJ ZIP: 07652 BUSINESS PHONE: 2012619300 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UROPLASTY INC CENTRAL INDEX KEY: 0000890846 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411719250 STATE OF INCORPORATION: MN FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78417 FILM NUMBER: 051254332 BUSINESS ADDRESS: STREET 1: 2718 SUMMER STREET NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123781180 MAIL ADDRESS: STREET 1: 2718 SUMMER ST NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 SC 13D/A 1 uroplasty055002_13da5.htm SCHEDULE 13D/A-6 Uroplasty, Inc., Form Schedule 13D/A-6, Dated: November 24, 2004

UNITED STATES
SECURITIES AND  EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 6)*


Uroplasty, Inc.

(Name of Issuer)



Common Stock, $.01 par value

(Title of Class of Securities)



917277204

(CUSIP Number)



Michael W. Schley, Esq.
Larkin Hoffman Daly & Lindgren Ltd.
1500 Wells Fargo Plaza
7900 Xerxes Avenue South
Minneapolis, MN 55431-1194
(952) 835-3800

(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)



November 24, 2004

(Date of Event Which Requires Filing of this Statement)



If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



CUSIP No. 917277204    

 

  1  

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).

 

            Bruce P. Mindich, M.D.

    
  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  

(b)  

    
  3  

SEC Use Only

 

    
  4  

Source of Funds (See Instructions)

 

            PF

    
  5  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

   ¨
  6  

Citizenship or Place of Organization

 

            United States

    

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  

  7    Sole Voting Power

 

                0

  8    Shared Voting Power

 

                886,427

  9    Sole Dispositive Power

 

                0

10    Shared Dispositive Power

 

                886,427

11  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

            886,427

    
12  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

  

¨

 

13  

Percent of Class Represented by Amount in Row (11)

 

            19.01%

   
14  

Type of Reporting Person (See Instructions)

 

            IN

   

 

Note: Information in this Amendment to Schedule 13D is as of the date of event shown on the cover page hereof, not the date of filing.

2


Item 1.   Security and Issuer

  The  name of the Issuer is Uroplasty, Inc. (the “Issuer”). Its principal office is at 2718 Summer Street N.E., Minneapolis, MN 55413. The title of the class of equity security to which this statement relates is Common Stock.

Item 2(a).   Names

  Statements are being filed simultaneously by Bruce P. Mindich, M.D. (“Bruce Mindich”), the Mindich Family Limited Liability Co. (“Mindich LLC”), and Helaine Brick-Cabot (“Brick-Cabot”) who affirm that they do not constitute a group (together, the “Reporting Persons”). This statement is being filed by Bruce Mindich.

Item 2(b).   Residence or Business Address

  The address of the Reporting Persons is:

  200 Route 17 North
Paramus, NJ 07652

Item 2(c).   Principal Occupation

  Bruce Mindich is a cardiac surgeon.

  Mindich LLC is a holding company.

  Brick-Cabot is an attorney.

Item 2(d).   Convictions

  None of the Reporting Persons have, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

Item 2(e).   Civil Litigation.

  Neither of the Reporting Persons have, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining further violation, or prohibiting activities subject to federal or state securities laws or finding any violation of such laws.

Item 2(f).   Citizenship.

  Bruce Mindich and Brick-Cabot are citizens of the United States. Mindich LLC is organized under the laws of Delaware.

Item 3.   Source and Amount of Funds or Other Consideration

  Funds were the personal funds of Reporting Persons. No part of the purchase price was borrowed or otherwise obtained for the purpose of acquiring, holding, trading or voting the securities.


3


Item 4.   Purpose of Transaction

  The Reporting Persons beneficially acquired the shares of common stock of the Issuer reported herein for investment purposes. The Reporting Persons reserve the right to purchase additional shares or to sell shares if they deem such action to be in their best interest.

  The Reporting Persons do not have any specific plans or proposals respecting:

  (i) any extraordinary corporate transactions affecting the Issuer such as a merger, reorganization, or liquidation;
  (ii) a sale or transfer of a material amount of the shares of the Issuer owned by them;
  (iii) changes in the Issuer’s board of directors or management or to change the number or term of directors or to fill any existing vacancies on the board;
  (iv) changes in the present capitalization or dividend policy of the Issuer;
  (v) any material changes to the business or corporate structure;
  (vi) any changes in the Issuer’s charter, bylaws or instruments which may impede the acquisition of control or the Issuer by any person;
  (vii) causing a class of securities of the Issuer to be delisted or to cease being authorized to be quoted;
  (viii) causing the termination of registration of any class of the Issuer’s securities;
  (ix) any similarly-enumerated actions.

Item 5(a).   Number of Shares Beneficially owned.

  Mindich LLC directly owns the following number of shares of common stock: 541,665.

  The securities reported on this Schedule as owned by Mindich LLC aggregate 541,665 shares and represent 11.62% of the outstanding common stock of the Issuer computed in accordance with Rule 13d-3.

  Bruce Mindich directly owns the following number of shares of common stock: 344,762 and is beneficial holder of 541,665 shares of common stock held by Mindich LLC.

  The securities reported on this Schedule as owned and beneficially owned by Bruce Mindich aggregate 886,427 shares and represent 19.01% of the outstanding common stock of the Issuer computed in accordance with Rule 13d-3.

  Brick-Cabot directly owns the following number of shares of common stock 9,000.

  By reason of Rule 13d-3 Brick-Cabot may be deemed to beneficially own the shares of common stock owned by Bruce Mindich and Mindich LLC.

  The securities reported on this Schedule as owned and beneficially owned by Brick-Cabot aggregate 895,427 shares and represent 19.20% of the outstanding common stock of the Issuer computed in accordance with Rule 13d-3.

  The number of shares outstanding used in calculating the foregoing percentages is based upon such information as reported in the Issuer’s Forms 10-QSB or 10-KSB or Proxy Statement most immediately preceding the Date of Event.


4


  (b). Bruce Mindich, Mindich LLC and Brick-Cabot share the power to vote or to direct the vote and to dispose of the shares described in Item 5(a) as owned by Mindich LLC.

    Bruce Mindich and Brick-Cabot share the power to vote or direct the vote and to dispose of the shares described in Item 5(a) as owned by Bruce Mindich.

    Brick-Cabot has sole power to vote or to direct the vote and to dispose of the shares described in Item 5(a) as owned by Brick-Cabot.

  (c). The Reporting Persons transactions in the shares and warrants of the Issuer since filing of the last amendment of this Schedule were as follows:

    Transactions attributable to all three filing persons include the following:

  All warrants held by Mindich LLC expired by their terms on July 31, 2004.

    Transactions attributable to Bruce Mindich and Brick-Cabot include (i) all transactions listed as attributed to all three filing persons, plus (ii) the following:

  All warrants held by Bruce Mindich expired by their terms on July 31, 2004.

  Bruce Mindich sold shares of common stock in open market transactions as follows:

Date of Sale Price Per
Share		 Number of
Shares Sold
6/10/04     $ 4.25    2,000  
6/15/04   $ 4.24    4,500  
6/18/04   $ 4.30    2,000  
6/21/04   $ 4.35    1,900  
6/22/04   $ 4.35    600  
6/23/04   $ 4.35    2,200  
6/25/04   $ 4.20    2,000  

    Transactions attributed to Brick-Cabot include (i) all transactions listed as attributed to all three filing persons, plus (ii) all transactions listed as attributed to Bruce Mindich and Brick-Cabot plus (ii) the following transactions attributable only to Brick-Cabot:

  Brick-Cabot sold shares of common stock in open market transactions as follows:

Date of Sale Price Per
Share		 Number of
Shares Sold
11/24/04     $ 5.00    1,000  

5


  (d). Not applicable.

  (e). Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

    Not applicable.

Item 7. Materials to Be Filed as Exhibits

    Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Dated: 11/17/05 /s/ Bruce P. Mindich, M.D.
 
 Bruce P. Mindich, M.D.



6


 -----END PRIVACY-ENHANCED MESSAGE-----